跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Necrostatin-1
首页
药物
Necrostatin-1
Necrostatin-1
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Application of Necrostatin-1 as neutrophile granulocyte apoptosis accelerant
CN 105078975 A
申请人: UNIV SOUTHERN MEDICAL
优先权: 2015
CN
Application of Necrostatin-1 in drugs for treating neurodegenerative eye disease
CN 107519165 A
申请人: ZHONGSHAN OPHTHALMIC CT SUN YAT SEN UNIV
优先权: 2017
CN
Nec-1/polydopamine/platinum particle/ferroferric oxide nano composite particle as well as preparation and application thereof
CN 116262104 A
申请人: UNIV EAST CHINA NORMAL
优先权: 2021
CN
DII-tt-DTT and application thereof in preparation of anti-colorectal cancer drugs
CN 115634223 A
申请人: UNIV HENAN
优先权: 2022
CN
Necrostatin-1在制备预防和/或治疗急性马兜铃酸肾病药物中的应用
CN 116459247 B
申请人: 河南省人民医院
优先权: 2023
CN
Application of necrostatin-1 in preparation of medicine for preventing and/or treating xerophthalmia
CN 122229838 A
申请人: BEIJING TONGREN HOSPITAL CAPITAL MEDICAL UNIV
优先权: 2026
CN
Application of Necrostatin-1 in preparation of medicine for preventing and/or treating nerve damage caused by Zika virus infection
CN 122461297 A
申请人: GUIZHOU MEDICAL UNIV
优先权: 2026
CN
药物
反馈